Process View
The appearance of chemokine (C-X-C motif) ligand 2 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "chemokine c x c motif ligand 2 production"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| HDAC2 | histone deacetylase 2 | 0.997 | ||
| HLA-DQA1 | major histocompatibility complex, class II, DQ alpha 1 | 0.326 | ||
| HLA-DRA | major histocompatibility complex, class II, DR alpha | 0.226 | ||
| HLA-DPA1 | major histocompatibility complex, class II, DP alpha 1 | 0.196 | ||
| IER2 | immediate early response 2 | 0.177 | ||
| SIN3A | SIN3 homolog A, transcription regulator (yeast) | 0.136 | ||
| ZFP36 | zinc finger protein 36, C3H type, homolog (mouse) | 0.133 | ||
| HLA-DMA | major histocompatibility complex, class II, DM alpha | 0.127 | ||
| MAP3K2 | mitogen-activated protein kinase kinase kinase 2 | 0.126 | ||
| MAP3K3 | mitogen-activated protein kinase kinase kinase 3 | 0.105 | ||
| DUSP1 | dual specificity phosphatase 1 | 0.101 | ||
| TNFRSF1B | tumor necrosis factor receptor superfamily, member 1B | 0.100 | ||
| HLA-DRB1 | major histocompatibility complex, class II, DR beta 1 and major histocompatibility complex, class II, DR beta 1 | 0.098 | ||
| EHMT2 | euchromatic histone-lysine N-methyltransferase 2 | 0.092 | ||
| CTBP1 | C-terminal binding protein 1 | 0.076 | ||
| HLA-DMB | major histocompatibility complex, class II, DM beta | 0.067 | ||
| TRADD | TNFRSF1A-associated via death domain | 0.066 | ||
| ATF3 | activating transcription factor 3 | 0.065 | ||
| MAPK7 | mitogen-activated protein kinase 7 | 0.058 | ||
| TLR4 | toll-like receptor 4 | 0.053 | ||
| RCOR1 | REST corepressor 1 | 0.053 | ||
| CXCR4 | chemokine (C-X-C motif) receptor 4 | 0.047 | ||
| SAMHD1 | SAM domain and HD domain 1 | 0.044 | ||
| NFKBIA | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | 0.044 | ||
| ASRGL1 | asparaginase like 1 | 0.044 | ||
| IRAK4 | interleukin-1 receptor-associated kinase 4 | 0.043 | ||
| TNFRSF1A | tumor necrosis factor receptor superfamily, member 1A | 0.041 | ||
| RBBP4 | retinoblastoma binding protein 4 | 0.041 | ||
| JUN | jun proto-oncogene | 0.039 | ||
| SAP30 | Sin3A-associated protein, 30kDa | 0.037 | ||
| MYD88 | myeloid differentiation primary response gene (88) | 0.037 | ||
| HLA-DPB1 | major histocompatibility complex, class II, DP beta 1 | 0.036 | ||
| FOSL2 | FOS-like antigen 2 | 0.035 | ||
| MAPK14 | mitogen-activated protein kinase 14 | 0.028 | ||
| ESR1 | estrogen receptor 1 | 0.026 | ||
| FOSB | FBJ murine osteosarcoma viral oncogene homolog B | 0.025 | ||
| KLF2 | Kruppel-like factor 2 (lung) | 0.024 | Human | |
| KLF4 | Kruppel-like factor 4 (gut) | 0.023 | ||
| CHD4 | chromodomain helicase DNA binding protein 4 | 0.022 | ||
| FOS | FBJ murine osteosarcoma viral oncogene homolog | 0.022 | ||
| DNMT3B | DNA (cytosine-5-)-methyltransferase 3 beta | 0.022 | ||
| TRAF7 | TNF receptor-associated factor 7 | 0.022 | ||
| CUX1 | cut-like homeobox 1 | 0.021 | ||
| TRAF1 | TNF receptor-associated factor 1 | 0.020 | ||
| RBBP7 | retinoblastoma binding protein 7 | 0.020 | ||
| RHOB | ras homolog gene family, member B | 0.020 | ||
| TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 | 0.019 | ||
| RIPK1 | receptor (TNFRSF)-interacting serine-threonine kinase 1 | 0.018 | ||
| KAT2B | K(lysine) acetyltransferase 2B | 0.017 | ||
| RERE | arginine-glutamic acid dipeptide (RE) repeats | 0.017 | ||
| HEMGN | hemogen | 0.017 | ||
| INADL | InaD-like (Drosophila) | 0.016 | ||
| POLH | polymerase (DNA directed), eta | 0.016 | ||
| TFAP2A | transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) | 0.015 | ||
| ANXA1 | annexin A1 | 0.015 | ||
| FADD | Fas (TNFRSF6)-associated via death domain | 0.015 | ||
| PPP1R15A | protein phosphatase 1, regulatory (inhibitor) subunit 15A | 0.015 | ||
| BCL11B | B-cell CLL/lymphoma 11B (zinc finger protein) | 0.014 | ||
| HDAC3 | histone deacetylase 3 | 0.014 | ||
| ING2 | inhibitor of growth family, member 2 | 0.014 | ||
| GADD45B | growth arrest and DNA-damage-inducible, beta | 0.014 | ||
| NFKBIZ | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta | 0.014 | ||
| JUNB | jun B proto-oncogene | 0.014 | ||
| SMURF1 | SMAD specific E3 ubiquitin protein ligase 1 | 0.013 | ||
| TSC22D3 | TSC22 domain family, member 3 | 0.013 | ||
| HLA-DQB1 | major histocompatibility complex, class II, DQ beta 1 | 0.013 | ||
| TRAF2 | TNF receptor-associated factor 2 | 0.013 | ||
| HCFC1 | host cell factor C1 (VP16-accessory protein) | 0.013 | ||
| EMP1 | epithelial membrane protein 1 | 0.013 | ||
| NEDD9 | neural precursor cell expressed, developmentally down-regulated 9 | 0.013 | ||
| DNAJB1 | DnaJ (Hsp40) homolog, subfamily B, member 1 | 0.012 | ||
| TGIF1 | TGFB-induced factor homeobox 1 | 0.012 | ||
| NR4A2 | nuclear receptor subfamily 4, group A, member 2 | 0.012 | ||
| CYR61 | cysteine-rich, angiogenic inducer, 61 | 0.011 | ||
| CSRNP1 | cysteine-serine-rich nuclear protein 1 | 0.011 | ||
| CBX5 | chromobox homolog 5 | 0.011 | ||
| ZFP36L2 | zinc finger protein 36, C3H type-like 2 | 0.011 | ||
| HLA-DRB4 | major histocompatibility complex, class II, DR beta 4 | 0.011 | ||
| ID1 | inhibitor of DNA binding 1, dominant negative helix-loop-helix protein | 0.011 | ||
| PROCR | protein C receptor, endothelial | 0.011 | ||
| MYADM | myeloid-associated differentiation marker | 0.011 | ||
| CMIP | c-Maf-inducing protein | 0.011 | ||
| IKZF1 | IKAROS family zinc finger 1 (Ikaros) | 0.011 | ||
| UHRF2 | ubiquitin-like with PHD and ring finger domains 2 | 0.011 | ||
| LAPTM5 | lysosomal protein transmembrane 5 | 0.010 | ||
| CDYL | chromodomain protein, Y-like | 0.010 | ||
| JOSD1 | Josephin domain containing 1 | 0.010 | ||
| EIF1 | eukaryotic translation initiation factor 1 | 0.010 | ||
| WWP2 | WW domain containing E3 ubiquitin protein ligase 2 | 0.010 | ||
| MTA1 | metastasis associated 1 | 0.010 |